Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia

Urology

Volumn 57, Issue 4 SUPPL. 1, 2001, Pages 185-187

  Clark, Larry C ^a   Marshall, James R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN; SELENOMETHIONINE;

ARTICLE; BASAL CELL CARCINOMA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; MALE; PROSTATE TUMOR; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; UNITED STATES;

ANTICARCINOGENIC AGENTS; ARIZONA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SELENOMETHIONINE; SKIN NEOPLASMS;

EID: 0035320577     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)00970-5     Document Type: Article

References (14)

1. Clark LC, Combs GF Jr, Tumbull BW, et al for the Nutritional Prevention of Cancer Study Group: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial [see comments] [published erratum appears in JAMA 1997 May 21;277(19):1520]. JAMA 276: 1957-1963, 1996.
2. Neve J: Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 9(2): 65-73, 1995.
3. Ip C: Lessons from basic research in selenium and cancer prevention. J Nutr 128: 1845-1854, 1998.
4. Bostwick DG, and Brawer MK: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788-794, 1987.
5. Gann PH, Hennekens CH, and Stampfer MJ: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer [see comments]. JAMA 273: 289-294, 1995.
6. Bostwick DG: Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30: 145-152, 1996.
7. Bostwick DG: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 78: 330-336, 1996.
8. Sakr WA, and Grignon DJ: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate. Anal Quant Cytol Histol 20: 417-423, 1998.
9. Bartels PH, da Silva VD, Montironi R, et al: Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol 20: 407-416, 1998.
10. Bartels PH, Montironi R, Thompson D, et al: Statistical histometry of the basal cell/secretory cell bilayer in prostatic intraepithelial neoplasia. Anal Quant Cytol Histol 20: 381-388, 1998.
11. Chodak GW, Thisted RA, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer [see comments]. N Engl J Med 330: 242-248, 1994.
12. Fleming C, Wasson JH, Albertsen PC, et al, for the Prostate Patient Outcomes Research Team: a decision analysis of alternative treatment strategies for clinically localized prostate cancer [see comments]. JAMA 269: 2650-2658, 1993.
13. Institute of Medicine: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press, 1999.
14. Colditz GA: Selenium and cancer prevention: promising results indicate further trials required [editorial; comment]. JAMA 276: 1984-1985, 1996.